The workshop was conducted as a part of the NITI–State workshop series
The R&D centre is mainly dedicated to the Process R&D of New Chemical Entities (NCE) development projects
Atlas AI combines NVIDIA BioNeMo cloud APIs for intelligent chemical and protein design
SyntheticGestalt will develop a pre-trained AI model to discover synthesizable drug-like hit candidates
Signs MoU with the Govt. of Gujarat at Vibrant Gujarat Summit
The company has received five final approvals
The company received gross proceeds of approximately US$1.7 million and net proceeds,
Ribo's cutting edge RIBO-GalSTAR platform enables the development of RNAi therapeutics targeting disease-causing genes specifically in hepatocytes
Subscribe To Our Newsletter & Stay Updated